Verastem (NASDAQ: VSTM) issues preliminary 2025 results and 2026 priorities

Rhea-AI Filing Summary

Verastem, Inc. filed a current report describing two related communications to the market. The company issued a press release with preliminary financial results for the quarter and full fiscal year ended December 31, 2025. These preliminary figures give an early view of Verastem’s recent operating performance.

In the same press release, Verastem also outlined its key strategic priorities for 2026, providing an overview of management’s focus areas for the coming year. The press release is furnished as an exhibit to the report, which is signed by Chief Executive Officer Daniel W. Paterson.

Insights

Equity research analyst

Verastem shares early 2025 results and 2026 focus areas.

Verastem released preliminary financial results for the quarter and year ended December 31, 2025, giving the market an advance look at recent performance ahead of full audited figures. Early disclosures like this often help frame expectations for upcoming detailed reports.

The company also used the same press release to describe its main strategic priorities for 2026, signaling management’s intended areas of emphasis. Actual implications for revenue, profitability, or capital needs will depend on the detailed numbers and strategy execution described in the full press release and future filings.

false 0001526119 0001526119 2026-02-04 2026-02-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): February 4, 2026

Verastem, Inc.

(Exact Name of Registrant as Specified in Charter)

Delaware		001-35403		27-3269467
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

117 Kendrick Street, Suite 500, Needham, MA		02494
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: (781) 292-4200

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock, $0.0001 par value per share		VSTM		The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 2.02. Results of Operations and Financial Condition

On February 4, 2026, Verastem, Inc. (the “Company”) issued a press release reporting preliminary financial results for the quarter and fiscal year ended December 31, 2025, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated into this Item 2.02.

Item 7.01 Regulation FD Disclosure

On February 4, 2026, the Company issued a press release outlining key 2026 strategic priorities, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits

Exhibit No.		Description
99.1		Press Release, dated February 4, 2026
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	VERASTEM, INC.
Dated: February 4, 2026	By:	/s/ Daniel W. Paterson
		Daniel W. Paterson
		Chief Executive Officer

FAQ

What did Verastem (VSTM) disclose in its latest current report?

Verastem disclosed that it issued a press release with preliminary financial results for the quarter and fiscal year ended December 31, 2025, and outlined key strategic priorities for 2026. The full press release is furnished as Exhibit 99.1 to the report.

Which period do Verastem’s preliminary financial results cover?

The preliminary financial results cover Verastem’s quarter and full fiscal year ended December 31, 2025. These early figures provide an initial view of the company’s recent operating performance before the release of complete, finalized financial statements in later filings.

How did Verastem communicate its 2026 strategic priorities to investors?

Verastem communicated its key 2026 strategic priorities through a press release issued on February 4, 2026. That same press release, furnished as Exhibit 99.1 to the current report, combines the company’s strategic outline with preliminary financial information for 2025.

Under which disclosure items did Verastem furnish the press release?

Verastem furnished the press release under Item 2.02, Results of Operations and Financial Condition, and Item 7.01, Regulation FD Disclosure. This indicates the release includes preliminary financial information and broader informational content intended for fair and simultaneous public disclosure.

Who signed Verastem’s current report covering preliminary 2025 results?

The current report was signed on behalf of Verastem by Daniel W. Paterson, the company’s Chief Executive Officer. His signature indicates that Verastem’s senior leadership is formally submitting the disclosure regarding preliminary 2025 financial results and 2026 strategic priorities.

Where can investors find the full Verastem press release from February 4, 2026?

Investors can find the full press release as Exhibit 99.1 attached to the current report. That exhibit contains Verastem’s preliminary quarter and year-end 2025 financial results alongside a description of the company’s key strategic priorities for 2026.